FDAnews
www.fdanews.com/articles/126256-immunogen-roche-issued-favorable-update-on-t-dm1-approval-plans

ImmunoGen: Roche Issued Favorable Update on T-DM1 Approval Plans

April 15, 2010
ImmunoGen, Inc. announced Thursday that Roche has provided a favorable update related to its plans to apply for marketing approval of trastuzumab-DM1, or T-DM1, in the US.
RTTNews